Triglycerides and atherogenic lipoproteins: rationale for lipid management.
about
A lecithin cholesterol acyltransferase-like gene mediates diacylglycerol esterification in yeast.Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamilyPharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network studyThe DGA1 gene determines a second triglyceride synthetic pathway in yeast.Cardiovascular risk beyond LDL-C levels. Other lipids are performers in cholesterol story.Morphological changes of parotid gland in experimental hyperlipidemia.New cholesterol guidelines, new treatment challenges.Triacylglycerol biosynthesis in yeast.Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell functionAtherosclerosis and physical activity.The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.The genetics of neutral lipid biosynthesis: an evolutionary perspectiveSynthesis of novel lipids in Saccharomyces cerevisiae by heterologous expression of an unspecific bacterial acyltransferase.Overweight adolescents with type 2 diabetes have significantly higher lipoprotein abnormalities than those with type 1 diabetesEffects of short-term feeding of a highly palatable diet on vascular reactivity in rats.Uric acid correlates with the severity of histopathological parameters in IgA nephropathy.Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TriaAutophagy-independent function of Atg8 in lipid droplet dynamics in yeast.Effect of n‐3 fatty acids on carotid atherosclerosis and haemostasis in patients with combined hyperlipoproteinemia: A double‐blind pilot study in primary prevention
P2860
Q27933801-CEE26659-0798-425C-9FA8-93D54EC9B9BEQ28118125-2D7567AF-838A-4739-B314-8143F641CC2CQ28302934-F95F4F9E-E682-40B4-864D-60D750FF1BE4Q30667251-4DBA8993-F483-4ADC-BF5F-8B7D774E165EQ34355011-89740810-9629-46F8-A87F-042A1A6D5BC6Q34725583-36F80F00-26C7-4C61-86A4-527571CD7913Q34748825-08B2B5F5-3B1E-485E-9D38-D51072788C9AQ35126164-B3B86D6E-8ACB-4ED8-A63E-084126F033DEQ35180903-DE6D66D4-2C55-4868-AE33-5A3FC189F9C8Q35651476-67708F0E-F4C7-4629-9C03-01FB78F43FACQ36137264-68AB9A31-10D0-47CA-BB60-CE7B33860511Q36359500-F15DCF3C-9D2B-42EB-B7FC-F707CABB00B5Q37264190-D79DBC59-2927-4A03-90F2-B6DE6D48A610Q37701971-FB8FC0F4-2AD9-4D41-B60F-A6E5C78291D9Q37730348-FC1E9CCF-F143-4AAE-8B8C-3D2DA5598090Q43923359-48ED5398-4F8F-4D60-97F9-DF64653F6AAFQ45168717-754760E4-1E14-41CF-8400-B4897A5BD67FQ50119076-4D07CB88-0868-4DFC-9A6B-E29D3A19641AQ50220769-66420F07-DB4C-45FC-A70E-F44EFA764849Q57398829-C200F108-A397-436C-B121-852ADF00DD83
P2860
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@en
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@nl
type
label
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@en
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@nl
prefLabel
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@en
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@nl
P1476
Triglycerides and atherogenic lipoproteins: rationale for lipid management.
@en
P2093
R M Krauss
P304
P356
10.1016/S0002-9343(98)00213-7
P407
P577
1998-07-01T00:00:00Z